×
About 120,620 results

ALLMedicine™ Rheumatoid Arthritis Center

Research & Reviews  51,895 results

Evaluation of the anti-rheumatic properties of thymol using carbon dots as nanocarriers...
https://doi.org/10.1039/d1fo00471a
Food & Function; Murugesan S, Srinivasan V et. al.

May 7th, 2021 - Rheumatoid Arthritis (RA) is an autoimmune disease that commences as inflammation and progressively destroys the articular joint. In this study, we assess the anti-rheumatic potential of the monoterpenoid class of thymol conjugated with Carbon Dot...

Current favourable 10-year outcome of patients with early rheumatoid arthritis: data fr...
https://doi.org/10.1093/rheumatology/keab398
Rheumatology (Oxford, England); Combe B, Rincheval N et. al.

May 7th, 2021 - To report the 10-year outcome of an inception cohort of patients with early rheumatoid arthritis (RA), the ESPOIR cohort, and predictors of outcome. From 2003 to 2005, 813 patients were included if they had early arthritis (< 6 months) with a high...

Longitudinal Changes in Knee Joint Synovial Vascularity in a Rabbit Model of Rheumatoid...
https://doi.org/10.1016/j.ultrasmedbio.2021.03.012
Ultrasound in Medicine & Biology; Liu H, Chen S et. al.

May 7th, 2021 - We studied a rabbit model of rheumatoid arthritis (RA) to examine the time course of changes in synovial neovascularization based on quantitative power Doppler ultrasound and contrast-enhanced ultrasound (CEUS). Twenty-five male New Zealand rabbit...

Cytokines in gingival crevicular fluid in elderly rheumatoid arthritis patients in a po...
https://doi.org/10.1111/jre.12887
Journal of Periodontal Research; Söderlin MK, Persson GR et. al.

May 6th, 2021 - We studied cytokines in gingival crevicular fluid (GCF) in a cross-sectional population-based cohort of rheumatoid arthritis (RA) patients ≥61 years of age with and without a diagnosis of periodontitis. Earlier studies on cytokines in GCF in RA pa...

Nonsurgical periodontal therapy decreases the severity of rheumatoid arthritis and the ...
https://doi.org/10.1007/s00784-021-03950-4 10.1038/nri3785 10.1038/nature01661 10.1111/jre.12482 10.1111/j.1600-051X.2010.01682.x 10.2334/josnusd.16-0677 10.1111/j.1600-051X.2010.01669.x 10.1111/prd.12344 10.1002/cre2.49 10.1186/s12903-020-1017-9 10.1016/S8756-3282(01)00682-2 10.1136/annrheumdis-2014-207137 10.1111/j.1600-051X.2011.01810.x 10.1902/jop.2013.130012 10.1016/j.autrev.2017.05.016 10.1038/nm0897-917 10.1186/ar1498 10.1186/ar4438 10.2174/1573397116666200116095039 10.1177/0022034509350708 10.1902/jop.2014.130718 10.1111/odi.13176 10.1371/journal.pone.0059498 10.1111/jcpe.12976 10.1007/s00296-013-2781-5 10.1007/s00784-018-2420-3 10.1002/art.1780380107 10.1111/j.1600-051X.2008.01249.x 10.1034/j.1600-0765.2001.00011.x 10.1002/JPER.18-0006 10.1002/art.27584.2010 10.1034/j.1600-051x.2000.027008578.x 10.3390/ijms17060846 10.1111/j.1600-051X.2012.01885.x 10.1186/s12967-015-0625-7 10.1902/jop.2016.160355 10.1111/1756-185X.13919 10.2174/1874210601812010435 10.1111/jcpe.12138 10.5005/jp-journals-10024-1877 10.1016/j.semarthrit.2020.01.009 10.1111/jcpe.13117 10.1093/rheumatology/ker090 10.1186/s12866-019-1608-2 10.1902/jop.2001.72.4.517 10.1002/jcp.21550 10.1186/ar2603 10.4103/2277-9175.180992
Clinical Oral Investigations; Moura MF, Silva TA et. al.

May 6th, 2021 - To investigate the influence of nonsurgical periodontal treatment (NSPT) on clinical periodontal status, rheumatoid arthritis (RA) activity, and plasmatic and salivary levels of biomarkers through a controlled clinical trial on individuals with RA...

see more →

Guidelines  237 results

Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function
https://onlinelibrary.wiley.com/doi/10.1002/acr2.11196
ACR Open Rheumatology; Liphardt AM

Nov 24th, 2020 - The objective of this study was to compare the impact of psoriatic disease (psoriatic arthritis [PsA] and psoriasis) and rheumatoid arthritis (RA) on objective and subjective parameters of hand function.

ACR Convergence 2020: Study Data for Lupus & Rheumatoid Arthritis
https://www.the-rheumatologist.org/article/acr-convergence-2020-study-data-for-lupus-rheumatoid-arthritis/
The Rheumatologist; Hickman RJ.

Nov 8th, 2020 - At the annual meeting’s second Plenary Session, Saturday, Nov. 7, speakers highlighted phase 2 results of a potential new biologic for systemic lupus erythematosus (SLE), as well as data on remission maintenance in rheumatoid arthritis (RA) after ...

ACR RA guidelines ‘push the needle away’ from glucocorticoids as primary option
https://www.healio.com/news/rheumatology/20201109/acr-ra-guidelines-push-the-needle-away-from-glucocorticoids-as-primary-option

Nov 7th, 2020 - Glucocorticoids should no longer be the “default” option for many patients with rheumatoid arthritis, according to authors of a new recommendation document presented at ACR Convergence 2020.

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
https://pubmed.ncbi.nlm.nih.gov/33154498/
Scientific Reports; Cohen IV, Makunts T et. al.

Nov 4th, 2020 - Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization's List of Essential Medications for treating non-resistant malaria, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). In addition, both drugs are cu...

Machine Learning Could Benefit Rheumatoid Arthritis Treatment with Sarilumab
https://www.hcplive.com/view/machine-learning-benefit-rheumatoid-arthritis-treatment-sarilumab

Nov 2nd, 2020 - As interleukin receptor (IL) inhibitors, the monoclonal antibody drug class has come to revolutionize fields of inflammatory disease care, though the utility and resourcing of such promising agents is yet to be fully refined. Namely, clinicians ca...

see more →

Drugs  3,303 results see all →

Clinicaltrials.gov  59,015 results

Evaluation of the anti-rheumatic properties of thymol using carbon dots as nanocarriers...
https://doi.org/10.1039/d1fo00471a
Food & Function; Murugesan S, Srinivasan V et. al.

May 7th, 2021 - Rheumatoid Arthritis (RA) is an autoimmune disease that commences as inflammation and progressively destroys the articular joint. In this study, we assess the anti-rheumatic potential of the monoterpenoid class of thymol conjugated with Carbon Dot...

Current favourable 10-year outcome of patients with early rheumatoid arthritis: data fr...
https://doi.org/10.1093/rheumatology/keab398
Rheumatology (Oxford, England); Combe B, Rincheval N et. al.

May 7th, 2021 - To report the 10-year outcome of an inception cohort of patients with early rheumatoid arthritis (RA), the ESPOIR cohort, and predictors of outcome. From 2003 to 2005, 813 patients were included if they had early arthritis (< 6 months) with a high...

Longitudinal Changes in Knee Joint Synovial Vascularity in a Rabbit Model of Rheumatoid...
https://doi.org/10.1016/j.ultrasmedbio.2021.03.012
Ultrasound in Medicine & Biology; Liu H, Chen S et. al.

May 7th, 2021 - We studied a rabbit model of rheumatoid arthritis (RA) to examine the time course of changes in synovial neovascularization based on quantitative power Doppler ultrasound and contrast-enhanced ultrasound (CEUS). Twenty-five male New Zealand rabbit...

Cytokines in gingival crevicular fluid in elderly rheumatoid arthritis patients in a po...
https://doi.org/10.1111/jre.12887
Journal of Periodontal Research; Söderlin MK, Persson GR et. al.

May 6th, 2021 - We studied cytokines in gingival crevicular fluid (GCF) in a cross-sectional population-based cohort of rheumatoid arthritis (RA) patients ≥61 years of age with and without a diagnosis of periodontitis. Earlier studies on cytokines in GCF in RA pa...

Nonsurgical periodontal therapy decreases the severity of rheumatoid arthritis and the ...
https://doi.org/10.1007/s00784-021-03950-4 10.1038/nri3785 10.1038/nature01661 10.1111/jre.12482 10.1111/j.1600-051X.2010.01682.x 10.2334/josnusd.16-0677 10.1111/j.1600-051X.2010.01669.x 10.1111/prd.12344 10.1002/cre2.49 10.1186/s12903-020-1017-9 10.1016/S8756-3282(01)00682-2 10.1136/annrheumdis-2014-207137 10.1111/j.1600-051X.2011.01810.x 10.1902/jop.2013.130012 10.1016/j.autrev.2017.05.016 10.1038/nm0897-917 10.1186/ar1498 10.1186/ar4438 10.2174/1573397116666200116095039 10.1177/0022034509350708 10.1902/jop.2014.130718 10.1111/odi.13176 10.1371/journal.pone.0059498 10.1111/jcpe.12976 10.1007/s00296-013-2781-5 10.1007/s00784-018-2420-3 10.1002/art.1780380107 10.1111/j.1600-051X.2008.01249.x 10.1034/j.1600-0765.2001.00011.x 10.1002/JPER.18-0006 10.1002/art.27584.2010 10.1034/j.1600-051x.2000.027008578.x 10.3390/ijms17060846 10.1111/j.1600-051X.2012.01885.x 10.1186/s12967-015-0625-7 10.1902/jop.2016.160355 10.1111/1756-185X.13919 10.2174/1874210601812010435 10.1111/jcpe.12138 10.5005/jp-journals-10024-1877 10.1016/j.semarthrit.2020.01.009 10.1111/jcpe.13117 10.1093/rheumatology/ker090 10.1186/s12866-019-1608-2 10.1902/jop.2001.72.4.517 10.1002/jcp.21550 10.1186/ar2603 10.4103/2277-9175.180992
Clinical Oral Investigations; Moura MF, Silva TA et. al.

May 6th, 2021 - To investigate the influence of nonsurgical periodontal treatment (NSPT) on clinical periodontal status, rheumatoid arthritis (RA) activity, and plasmatic and salivary levels of biomarkers through a controlled clinical trial on individuals with RA...

see more →

News  6,021 results

Therapeutic Drug Monitoring Has Little Value During Infliximab Induction
https://www.medscape.com/viewarticle/950456

May 4th, 2021 - NEW YORK (Reuters Health) - Results of a randomized controlled trial do not support routine use of proactive therapeutic drug monitoring (TDM) during infliximab induction for improving disease remission rates in patients with rheumatoid arthritis ...

With RA in Remission, Tapering of Conventional DMARDs May Lead to Disease Flares for Some Patients
https://www.medscape.com/viewarticle/950455

May 4th, 2021 - NEW YORK (Reuters Health) - In patients with rheumatoid arthritis (RA) in remission taking conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), cutting the drug dose in half could lead to more disease flares, according to a ran...

Baricitinib Continuation Rate High in Real-World Practice
https://www.medscape.com/viewarticle/950481

May 3rd, 2021 - Around three-quarters of patients remained on treatment with baricitinib (Olumiant) for rheumatoid arthritis after their first 6-month assessment in an independent analysis of British Society for Rheumatology Biologics Register (BSRBR) data. The r...

EMA to Quickly Review Eli Lilly, Incyte Arthritis Drug for COVID-19 Use
https://www.medscape.com/viewarticle/950192

Apr 29th, 2021 - ZURICH (Reuters) - The European Medicines Agency will conduct an accelerated review of Eli Lilly and Co's rheumatoid arthritis drug Olumiant for hospitalized COVID-19 patients getting oxygen, the agency said on Thursday, as the search for treatmen...

RA Biologic's Serious Infection Risk Confounded by Order of Use
https://www.medscape.com/viewarticle/950083

Apr 27th, 2021 - The order in which tocilizumab (Actemra) is used in the sequence of treatments for rheumatoid arthritis could be muddying the waters when it comes to evaluating patients' risk for serious infection. According to new data emerging from the British ...

see more →

Patient Education  149 results see all →